FDA: Janet Woodcock becomes acting commissioner
Dr. Janet Woodcock has been appointed as acting commissioner of the FDA. The previous commissioner, Dr. Stephen M. Hahn, stepped down from his role at the start of President Biden's term of office.
Janet Woodcock already has a 30-year career at FDA. Most recently, she led the CDER (US FDA Center for Drug Evaluation and Research). Since May 2020, she has also been responsible for leading Operation Warp Speed to support the development of COVID-19 therapeutics. Woodcock will continue to perform this function.
As she says, she welcomes the challenge of leading FDA on a transitional basis because:
"The FDA’s public health work is more critical than ever as we continue to fight this global pandemic."
Sources:
FDA: Janet Woodcock
Twitter: Janet Woodcock
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
